The TransCatheter Valve and Vessels Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 172 participants.
Also called NCT03424941
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 172 participants
- Sponsor
- Registry
-
NCT03424941
-
- Other papers using this trial's data
- TransCatheter aortic valve implantation and fractional flow reserve-guided percutaneous coronary intervention versus conventional surgical aortic valve replacement and coronary bypass grafting for treatment of patients with aortic valve stenosis and complex or multivessel coronary disease (TCW): an international, multicentre, prospective, open-label, non-inferiority, randomised controlled trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Austria, Denmark, France, Germany, Greece, Netherlands, Poland, Portugal, Slovakia, Spain
- Registry status
- Completed
Technical summary
Registry record NCT03424941. Randomized; no masking; primary purpose treatment. Start 2018-05-31 (actual); primary completion 2024-06-26 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The TransCatheter Valve and Vessels Trial
- Acronym
- TCW
- Condition
- Aortic Stenosis
- Condition
- Multi Vessel Coronary Artery Disease
- Condition
- TAVI
- Condition
- Fractional Flow Reserve
- Intervention (Device)
- FFR-guided PCI and TAVI
- Intervention (Device)
- CABG and SAVR
- Lead sponsor
- Maatschap Cardiologie Zwolle
- Collaborator
- Medtronic
Record details
- Record id
cardio:ct-nct03424941- Content hash
309a10c518268e8271f8e1a5f6a6961678d049ab76b78d1c9fd5d38562c63b73